EcoDrugPlus

Ensembl ID : ENSDLAG00005012294
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSDLAG00005012352
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSDLAG00005013499
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSDLAG00005013114
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSDLAG00005013752
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSDLAG00005013874
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSDLAG00005014307
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSDLAG00005013861
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSDLAG00005016433
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSDLAG00005016530
Gene Symbol: -
Cross references: -
330 Possible Orthologues:

Ensembl ID : ENSDLAG00005016672
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSDLAG00005016867
Gene Symbol: -
Cross references: -
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).